Additive Formula 3 NDC 14537-833

NDC codes

FDA NDC Directory

Product NDC (as listed)14537-833Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14537-0833Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
14537-833-03	14537083303	30 BAG in 1 CASE (14537-833-03) / 200 mL in 1 BAG (14537-833-00)Marketed from May 29, 2002

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Additive Formula 3
Generic name (nonproprietary): dextrose monohydrate, trisodium citrate dihydrate, sodium chloride, sodium phosphate, monobasic, monohydrate, citric acid monohydrate, and adenine
Active ingredients: Dextrose monohydrate — 1.1 g/100mLTrisodium citrate dihydrate — .59 g/100mLSodium chloride — .41 g/100mLSodium phosphate, Monobasic, Monohydrate — .28 g/100mLCitric acid monohydrate — .042 g/100mLAdenine — .03 g/100mL
Dosage form: Solution
Route: Intravenous
Labeler: Terumo BCT, Ltd
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication BN 001214
Marketing start: May 29, 2002
Listing expires: Dec 31, 2027
Other FDA classes: Acidifying Activity (Mechanism)Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 14537-833_a93abdba-f409-4b1b-b0d7-ece2189573d9SPL ID a93abdba-f409-4b1b-b0d7-ece2189573d9SPL set ID 9a5247a1-cc05-442d-b2d0-950f887f03c2UNII LX22YL083G, JAC85A2161, 593YOG76RN, 2968PHW8QP, B22547B95K, 451W47IQ8X
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N414537083303 followed by a unit qualifier and the quantity

Package 14537-0833-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2026.

Indications (excerpt from the label)

Use only with Trima Accel red blood cell (RBC) apheresis collections. [See Dosage and Administration (2) .] Use only with Trima Accel red blood cell (RBC) apheresis collections. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under BN 001214

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BN 001214
Product	Strength	Form · route	Labeler	Product NDC
Additive Formula 3dextrose monohydrate, trisodium citrate dihydrate, sodium chloride, sodium phosphate, monobasic, monohydrate, citric acid monohydrate, and adenine	Dextrose monohydrate 1.1 g/100mL + 5 more ingredients	SolutionIntravenous	Terumo BCT, Ltd	14537-832